Bicifadine

N/A

Report date: 2024/05/23 20:00:04
NME

Base Information

Drug NameBicifadine
Drug Alias Namebicifadina比西发啶bicifadinum比西发定bicifadine +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNorepinephrine transporter inhibitorsBeta adrenergic receptors antagonistsDopamine transporter antagonists +[5] 
TargetsNorepinephrine transporterBeta adrenergic receptorsDopamine transporter +[5] 
Therapy Area/IndicationsDiabetic peripheral neuropathyLow Back PainNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEuthymics Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXtl BiopharmaceuticalsEuthymics Bioscience Inc
Active IndicationsN/A
Inactive IndicationsDiabetic peripheral neuropathyLow Back PainNeuralgia

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG